Yun Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Yun Zhang has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Xinxin Han
State Key Laboratory of Complex Severe and Rare Diseases (Peking Union Medical College Hospital)
2 shared publications - Xuejun Zeng
Division of General Internal Medicine, Department of Family Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, State Key Laboratory of Complex Severe and Rare Diseases (Peking Union Medical College Hospital), China
2 shared publications - Yu Cao
Division of Endocrinology and Metabolism, Department of Medicine, University of California San Diego, San Diego, USA
2 shared publications - Hong Jie Di
Centre for Soil and Environmental Research, Lincoln University, Lincoln, Christchurch 7647, New Zealand
1 shared publication Jing Wang
Department of Emergency Medicine, Beijing Tongren Hospital, Capital Medical University, Beijing, China
1 shared publicationXiaoli Yuan
Department of Emergency Medicine, Beijing Tongren Hospital, Capital Medical University, Beijing, China
1 shared publication
Latest Publications
- Open Access
- 1 January 2021
- Published by AME Publishing Company in Translational Andrology and Urology
- Vol. 10 (1) , 272-282
Exploration of the association between serum uric acid and testosterone in adult males: NHANES 2011–2016
Background: Previous studies have suggested that the possible relationship between serum uric acid (SUA) and testosterone. However, the results of previous studies are controversial and there is limited evidence examining the relationship between SUA and testosterone in a general US population of men. The objective of this study is to explore the correlation of SUA and testosterone among adult males from the US. Methods: Data from the National Health and Nutrition Examination Survey 2011–2016 were used, including a total of 7,796 male participants aged 18 years or older and excluding those lacking serum testosterone and uric acid data. Clinical characteristics of the participants among different SUA groups and testosterone groups are compared. Univariate and multivariate linear regression analyses were applied to evaluate the association between SUA and testosterone. Results: We found an inverse association between SUA and testosterone after fully adjusted the potential confounding factors in general US adult males. In the multivariate linear regression analysis, we found that increasing age (estimate testosterone percent difference: −0.20% per year, PConclusions: SUA levels might be negatively associated with serum testosterone in adult males.
- 1 January 2021
- Published by AME Publishing Company in Translational Andrology and Urology
- Vol. 10 (1) , 272-282
Open AccessExploration of the association between serum uric acid and testosterone in adult males: NHANES 2011–2016
Background: Previous studies have suggested that the possible relationship between serum uric acid (SUA) and testosterone. However, the results of previous studies are controversial and there is limited evidence examining the relationship between SUA and testosterone in a general US population of men. The objective of this study is to explore the correlation of SUA and testosterone among adult males from the US. Methods: Data from the National Health and Nutrition Examination Survey 2011–2016 were used, including a total of 7,796 male participants aged 18 years or older and excluding those lacking serum testosterone and uric acid data. Clinical characteristics of the participants among different SUA groups and testosterone groups are compared. Univariate and multivariate linear regression analyses were applied to evaluate the association between SUA and testosterone. Results: We found an inverse association between SUA and testosterone after fully adjusted the potential confounding factors in general US adult males. In the multivariate linear regression analysis, we found that increasing age (estimate testosterone percent difference: −0.20% per year, PConclusions: SUA levels might be negatively associated with serum testosterone in adult males.
- Open Access
- 1 December 2020
- Published by SAGE Publications in Natural Product Communications
- Vol. 15 (12)
Tubeimoside-1 Protects Against Renal Ischemia Reperfusion Injury In Vivo and In Vitro
Renal ischemia reperfusion injury (RIRI) is one of the main causes of acute kidney injury. This study aimed to explore whether tubeimoside-1 (TBMS1) could protect against RIRI. RIRI mice model and hypoxia/reoxygenation (H/R)-induced NRK-52E cells were used in this study. The renal pathology was observed by hematoxylin and eosin staining to calculate the tubular injury score. The levels of serum creatinine and blood urine nitrogen were analyzed by a Hitachi model 7180 automatic analyzer. The expressions of tumor necrosis factor alpha (TNF-α), interleukin-1 beta (IL-1β), interleukin 6 (IL-6), Bax, cleaved caspase-3, cleaved caspase-9, total caspase-3, and total caspase-9 in renal tissues and NRK-52E cells were detected by western blot analysis. The levels of TNF-α, IL-1β, and IL-6 in serum and NRK-52E cells were measured by a commercial enzyme-linked immunosorbent assay kit. The renal cell apoptosis in renal tissues was analyzed by TUNEL assay, and NRK-52E cell apoptosis was detected by flow cytometry analysis. CCK-8 assay was used to analyze the viability of NRK-52E cells after the indicated treatment. As a result, the renal tissues that were seriously damaged in mice with RIRI could be alleviated by TBMS1. Therefore, 50 mg/kg TBMS1 was chosen for the animal experiment. Renal cell apoptosis was increased in renal tissues of mice with RIRI. These changes could be partially reversed by TBMS1 treatment. TBMS1 improved the viability, and reduced the inflammation and apoptosis of H/R-induced NRK-52E cells. In conclusion, TBMS1 ameliorates RIRI by promoting viability and suppressing apoptosis and inflammation of renal cells.
- 1 December 2020
- Published by SAGE Publications in Natural Product Communications
- Vol. 15 (12)
Open AccessTubeimoside-1 Protects Against Renal Ischemia Reperfusion Injury In Vivo and In Vitro
Renal ischemia reperfusion injury (RIRI) is one of the main causes of acute kidney injury. This study aimed to explore whether tubeimoside-1 (TBMS1) could protect against RIRI. RIRI mice model and hypoxia/reoxygenation (H/R)-induced NRK-52E cells were used in this study. The renal pathology was observed by hematoxylin and eosin staining to calculate the tubular injury score. The levels of serum creatinine and blood urine nitrogen were analyzed by a Hitachi model 7180 automatic analyzer. The expressions of tumor necrosis factor alpha (TNF-α), interleukin-1 beta (IL-1β), interleukin 6 (IL-6), Bax, cleaved caspase-3, cleaved caspase-9, total caspase-3, and total caspase-9 in renal tissues and NRK-52E cells were detected by western blot analysis. The levels of TNF-α, IL-1β, and IL-6 in serum and NRK-52E cells were measured by a commercial enzyme-linked immunosorbent assay kit. The renal cell apoptosis in renal tissues was analyzed by TUNEL assay, and NRK-52E cell apoptosis was detected by flow cytometry analysis. CCK-8 assay was used to analyze the viability of NRK-52E cells after the indicated treatment. As a result, the renal tissues that were seriously damaged in mice with RIRI could be alleviated by TBMS1. Therefore, 50 mg/kg TBMS1 was chosen for the animal experiment. Renal cell apoptosis was increased in renal tissues of mice with RIRI. These changes could be partially reversed by TBMS1 treatment. TBMS1 improved the viability, and reduced the inflammation and apoptosis of H/R-induced NRK-52E cells. In conclusion, TBMS1 ameliorates RIRI by promoting viability and suppressing apoptosis and inflammation of renal cells.
- Open Access
- 28 October 2020
- Published by Wolters Kluwer Health in Chinese Medical Journal
- Vol. 134 (7) , 854-856
Early onset gout and chronic kidney disease in a young female patient
An abstract is unavailable. This article is available as a PDF only.
- 28 October 2020
- Published by Wolters Kluwer Health in Chinese Medical Journal
- Vol. 134 (7) , 854-856
Open AccessEarly onset gout and chronic kidney disease in a young female patient
An abstract is unavailable. This article is available as a PDF only.